German pharmaceutical company Merck said on Friday that its anti-Covid pill was found to be 20% less effective in a final analysis of a clinical trial. The drug, called molnupiravir, was initially estimated to cut the risk of hospitalization and death by 50% when taken by high-risk individuals soon after they had become infected. The […]
Read the full story on GreekReporter.com.